CSat Investment Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | $5K | Buy |
86
+28
| +48% | +$1.63K | ﹤0.01% | 489 |
|
|
2020
Q4 | $4K | Sell |
58
-14,714
| -100% | -$1.01M | ﹤0.01% | 489 |
|
|
2020
Q3 | $891K | Sell |
14,772
-2,713
| -16% | -$164K | 0.08% | 114 |
|
|
2020
Q2 | $1.03M | Buy |
17,485
+3,278
| +23% | +$193K | 0.12% | 85 |
|
|
2020
Q1 | $792K | Buy |
14,207
+1,919
| +16% | +$107K | 0.17% | 84 |
|
|
2019
Q4 | $789K | Buy |
12,288
+3,125
| +34% | +$201K | 0.21% | 95 |
|
|
2019
Q3 | $465K | Buy |
9,163
+2,292
| +33% | +$116K | 0.15% | 135 |
|
|
2019
Q2 | $311K | Buy |
6,871
+3,166
| +85% | +$143K | 0.11% | 144 |
|
|
2019
Q1 | $177K | Buy |
3,705
+1,570
| +74% | +$75K | 0.09% | 130 |
|
|
2018
Q4 | $111K | Buy |
2,135
+255
| +14% | +$13.3K | 0.07% | 136 |
|
|
2018
Q3 | $117K | Sell |
1,880
-160
| -8% | -$9.96K | 0.07% | 129 |
|
|
2018
Q2 | $113K | Buy |
+2,040
| New | +$113K | 0.06% | 141 |
|